Our capabilities and experience

Read more about how we help manage complex clinical research across many therapeutic areas worldwide.

  • Resource Type

  • Services

  • Indication

  • Reset filters
Found 49 Results
Page 1 of 5
Brochure

Full-Service Global Support for COVID-19 Studies

Our broad expertise, end-to-end services and ability to begin immediate collaboration with government, commercial and academic partners in more than 60 countries make us uniquely positioned to support the COVID-19 response. We address emerging pandemics, epidemics and outbreaks with expertise that supports health and research efforts globally. We are experienced in addressing the complex aspects of infectious diseases — from infection prevention and control to clinical research on diagnostics, vaccines and treatment.


Indication Overview

Our Clinical Trial Experience With Malaria

For more than 10 years, the FHI Clinical project team has partnered with companies developing and deploying vaccines, treatments and preventive devices for malaria in 35 countries worldwide.


Video

Participant Recruitment and Retention Can Require Agile Solutions

Participant recruitment and retention can be challenged by many factors such as a long follow-up period, lack of accessible sites and unclear expectations. Our team helps develop and implement agile solutions to overcome these difficulties, as described in this video for multiple studies including a global, multi-site oncology trial.


Indication Overview

Our Clinical Trial Experience With Oncology

For nearly 20 years, the FHI Clinical project team has partnered with companies developing and deploying vaccines, treatments and diagnostic tests for multiple oncology indications.


Video

Project Profile: COVID-19 Study in Ghana

Investigating existing treatments for their efficacy to treat COVID-19 is important in some countries with limited access to new treatments, such as Ghana. In this project profile, Loice Magaria, Clinical Research Project Manager at FHI Clinical, discusses a study we’re supporting in Ghana to investigate COVID-19 treatments.


Video

Following the Epidemiology in Infectious Disease Trials: A COVID-19 Case Study

With infectious disease outbreaks, expanding immunity from previous infection and vaccination efforts can change where the outbreak is occurring. In this video, Loice Magaria, Clinical Research Project Manager at FHI Clinical discusses strategies implemented to address changing epidemiology in a study investigating COVID-19 treatments.


Video

Cultural Competence in Clinical Research

Cultural competence is important when interacting with local communities in a research setting. Our localized team members provide valuable insight into the language and culture of their communities and are skilled at cultural humility when working with teams and populations in other regions.


Brochure

Vaccine Development

Vaccines are critical to the eradication of infectious diseases worldwide. To achieve the FHI Clinical vision of a world where advances in vaccines help all people live longer, healthier lives, we’ve spent years honing our processes to respond to the urgency and complexity of vaccine trials, developing our global network of research-ready investigators and sites, and partnering with leading public and private medical research organizations, pharmaceutical and biotechnology companies, academic institutions, governments and non-governmental organizations.


Webinar

Africa’s Potential for Clinical Research

In this webinar, our panel of Africa-based researchers discuss the strong clinical research foundation, the community-centered approach and increasing regulatory harmonization in Africa. Watch to learn about the continent’s population diversity, expanding therapeutic area expertise and long-standing stakeholder engagement.


Video

Global Vaccine Development

To achieve our vision of a world where advances in vaccines help all people live longer, healthier lives, we’ve honed our processes to respond to the urgency and complexity of vaccine trials, developed our global network of investigators and sites, and partnered with organizations across public, private, academic and government sectors.